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Constraint-based reconstruction and analysis (COBRA) methods at the genome scale have been
under development since the first whole-genome sequences appeared in the mid-1990s. A few
years ago, this approach began to demonstrate the ability to predict a range of cellular functions,
including cellular growth capabilities on various substrates and the effect of gene knockouts at the
genome scale. Thus, much interest has developed in understanding and applying thesemethods to
areas such asmetabolic engineering, antibiotic design, and organismal and enzyme evolution. This
Primer will get you started.
Introduction
Bottom-up approaches to systems biology rely on constructing
a mechanistic basis for the biochemical and genetic processes
that underlie cellular functions. Genome-scale network recon-
structions of metabolism are built from all known metabolic
reactions and metabolic genes in a target organism. Networks
are constructed based on genome annotation, biochemical
characterization, and the published scientific literature on the
target organism; the latter is sometimes referred to as the bib-
liome. DNA sequence assembly provides a useful analogy to
the process of network reconstruction (Figure 1). The genome
of an organism is systematically assembled from many short
DNA stubs, called reads, using sophisticated computer algo-
rithms. Similarly, the reactome of a cell is assembled, or recon-
structed, from all the biochemical reactions known or predicted
to be present in the target microorganism. Importantly, network
reconstruction includes an explicit genetic basis for each
biochemical reaction in the reactome as well as information
about the genomic location of the gene. Thus, reconstructed
networks, or an assembled reactome, for a target organism
represent biochemically, genetically, and genomically structured
knowledge bases, or BiGG k-bases. Network reconstructions
have different biological scope and coverage. They may
describe metabolism, protein-protein interactions, regulation,
signaling, and other cellular processes, but they have a unifying
aspect: an embedded, standardized biochemical and genetic
representation amenable to computational analysis.
A network reconstruction can be converted into a mathemat-
ical format and thus lend itself to mathematical analysis and
computational treatment. Genome-scale models, called GEMs,
have been under development for nearly 15 years and have
now reached a high level of sophistication. The first GEM
was created for Haemophilus influenza and appeared shortly
after this first genome was sequenced (Edwards and Palsson,
1999), and GEMs have now grown to the level where they
enable predictive biology (Bordbar et al., 2014; McCloskey
et al., 2013; Oberhardt et al., 2009). Here, we will focus on recon-
structions of metabolism and the process of converting them
into GEMs to produce computational predictions of biological
functions.
The fundamentals of the constraints-based reconstruction
and analysis (COBRA) approach and its uses are also described
in this Primer, which lays out the constraint-based methodology
at four levels. First, there is a textual description of the methods
and their applications. Second, visualization is presented in
the form of detailed figures to succinctly convey the key con-
cepts and applications. Third, the figure captions contain more
detailed information about the computational approaches
illustrated in the figures. Fourth, the Primer provides a table of
selected detailed resources to enable an in-depth review for
the keenly interested reader. The text is organized into six sec-
tions, each addressing a grand challenge in today’s world of
‘‘big data’’ biology.
1. Network Reconstructions Assemble Knowledge
Systematically
There is a large library of scientific publications that describe
different model organisms’ specific molecular features. Molecu-
lar biology’s focus on knowing much about a limited number of
molecular events changed once annotated genome sequences
became available, leading to the emergence of a genome-scale
point of view. Now, putting all available knowledge about the
molecular processes of a target organism in context and linking
it to its genome sequence has emerged as a grand challenge.
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Genome-scale network reconstructions were a response to this
challenge.
Network Reconstructions Organize Knowledge
into a Structured Format
The reconstruction process treats individual reactions as the
basic elements of a network, somewhat similar to a base pair be-
ing the smallest element in an assembled DNA sequence
(Figure 1). To implement the metabolic reconstruction process,
a series of questions needs to be answered for each of the en-
zymes in a metabolic network. (1) What are the substrates and
products? (2) What are the stoichiometric coefficients for each
metabolite that participates in the reaction (or reactions) cata-
lyzed by an enzyme? (3) Are these reactions reversible? (4) In
what cellular compartment does the reaction occur? (5) What
gene(s) encode for the protein (or protein complex), and what
is (are) their genomic location(s)? Genes are linked to the pro-
teins they encode and the reactions they catalyze using the
gene-protein-reaction relationship (GPR). All of this information
is assembled from a range of sources, including organism-spe-
cific databases, high-throughput data, and primary literature.
Establishing a set of the biochemical reactions that constitute
a reaction network in the target organism culminates in a data-
base of chemical equations. Reactions are then organized
into pathways, pathways into sectors (such as amino acid syn-
thesis), and ultimately into genome-scale networks, akin to reads
becoming a full DNA sequence. This process has been
described in the form of a 96-step standard operating procedure
(Thiele and Palsson, 2010).
Today, after many years of hard work by many researchers,
there exist collections of genome-scale reconstructions (some-
times called GENREs) for a number of target organisms (Monk
et al., 2014; Oberhardt et al., 2011), and established protocols
for reconstruction exist (Thiele and Palsson, 2010) that can be
partially automated (Agren et al., 2013; Henry et al., 2010a).
Figure 1. Network Reconstruction
An organism’s reactome can be assembled in
a way that is analogous to DNA-sequencing
assembly. (Right to left) First the interacting com-
pounds must be identified. Then, the reactions
acting on these compounds are tabulated and
the protein that catalyzes the reaction and the
corresponding open reading frame is identified
in the organism of interest. These reactions are
assembled into pathways that can be laid out
graphically to visualize a cell’s metabolic map at
the genome scale. Several tools for reactome
assembly and curation exist, including the COBRA
Toolbox (Ebrahim et al., 2013; Schellenberger
et al., 2011b), KEGG (Kanehisa et al., 2014),
EcoCyc (Keseler et al., 2013), ModelSeed (Henry
et al., 2010b), BiGG (Schellenberger et al., 2010),
Rbionet (Thorleifsson and Thiele, 2011), Subliminal
(Swainston et al., 2011), Raven toolbox (Agren
et al., 2013), and others.
Recapitulation
Network reconstructions represent an
organized process for genome-scale as-
sembly of disparate information about a
target organism. All of this information is
put into context with the annotated genome to form a coherent
whole that, through computations, is able to recapitulate
whole-cell functions. The grand challenge of disparate data inte-
gration into a coherent whole is achieved through the formulation
of a GEM. A GEM can then compute cellular states such as an
optimal growth state. This process is further explored in the
next section. A detailed reading list is available in Table S1 on
the network reconstruction process and software tools used to
facilitate it.
2. Converting a Genome-scale Reconstruction
to a Computational Model
Before a reconstruction can be used to compute network prop-
erties, a subtle but crucial step must be taken in which a network
reconstruction is mathematically represented. This conversion
translates a reconstructed network into a chemically accurate
mathematical format that becomes the basis for a genome-scale
model. This conversion requires the mathematical representa-
tion of metabolic reactions. The core feature of this representa-
tion is tabulation, in the form of a numerical matrix, of the
stoichiometric coefficients of each reaction (Figure 2A). These
stoichiometries impose systemic constraints on the possible
flow patterns (called a flux map, or flux distribution) of metabo-
lites through the network. These concepts are detailed below.
Imposition of constraints on network functions fundamentally
differentiates the COBRA approach from models described by
biophysical equations, which require many difficult-to-measure
kinetic parameters.
Constraints are mathematically represented as equations that
represent balances or as inequalities that impose bounds
(Figure 2B). The matrix of stoichiometries imposes flux balance
constraints on the network, ensuring that the total amount of
any compound being produced must be equal to the total
amount being consumed at steady state. Every reaction can
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also be given upper and lower bounds, which define the
maximum and minimum allowable fluxes through the reactions
that, in turn, are related to the turnover number of the enzyme
and its abundance. Once imposed on a network reconstruction,
these balances and bounds define a space of allowable flux dis-
tributions in a network—the possible rates at which everymetab-
olite is consumed or produced by every reaction in the network.
The flux vector, a mathematical object, is a list of all such flux
values for a single point in the space. The flux vector represents
a ‘‘state’’ of the network that is directly related to the physiolog-
ical function that the network produces. Many other constraints
such as substrate uptake rates, secretion rates, and other limits
on reaction flux can also be imposed, further restricting the
possible state that a reconstructed network can take (Reed,
2012). The computed network states that are consistent with
all imposed constraints are thus candidate physiological states
of the target organisms under the conditions considered. The
study of the properties of this space thus becomes an important
subject.
Flux Balance Analysis Calculates Candidate Phenotypes
Flux balance analysis (FBA) is the oldest COBRA method. It is a
mathematical approach for analyzing the flow of metabolites
through a metabolic network (Orth et al., 2010). This approach
relies on an assumption of steady-state growth and mass
balance (all mass that enters the system must leave). The con-
straints discussed above take the form of equalities and inequal-
ities to define a polytope (blue area within the illustration in
Figure 2B) that represents all possible flux states of the network
given the constraints imposed. Thus, many network states are
possible under the given constraints, andmultiple solutions exist
that satisfy the governing equations. The blue area is therefore
often called the ‘‘solution space’’ to denote a mathematical
space that is filled with candidate solutions to the network
Figure 2. Formulation of a Computational Model
(A) After the metabolic network has been assembled, it must be converted into
a mathematical representation. This conversion is performed using a stoi-
chiometric (S) matrix in which the stoichiometry of each metabolite involved in
a reaction is enumerated. Reactions form the columns of this matrix and
metabolites the rows. Each metabolite’s entry corresponds to its stoichio-
metric coefficient in the corresponding reaction. Negative coefficient sub-
strates are consumed (reactants), and positive coefficients are produced
(products). Converting a metabolic network reconstruction to a mathematical
formulation can be achieved with several of the toolboxes listed in Table S1.
(B) Constraints can be added to the model, such as: (1) enforcement of mass
balance and (2) reaction flux (v) bounds. The blue polytope represents different
possible fluxes for reactions 5 and 6, consistent with stated constraints.
Those outside of the polytope violate the imposed constraints and are thus
‘‘infeasible.’’
(C) Constraint-based models predict the flow of metabolites through a defined
network. The predicted path is determined using linear programming solvers
and is termed flux balance analysis (FBA). FBA can be used to calculate
the optimal flow of metabolites from a network input to a network output. The
desired output is described by an objective function. If the objective is to
optimize flux through reaction 5, the optimal flux distribution would correspond
to the levels of flux 5 and flux 6 at the blue point circled in the figure. The
objective function can be a simple value or can draw on a combination of
outputs, such as the biomass objective shown in (E). It is important to note that
alternate optimal flux distributions may exist to reach the optimal state, as
discussed in Figure 4C.
(D) Once a network reconstruction is converted to a mathematical format,
the inputs to the system must be defined by adding consideration of the
extracellular environment. Compounds enter and exit the extracellular
environment via ‘‘exchange’’ reactions. The GEM will not be able to import
compounds unless a transport reaction from the external environment to the
inside of the cell is present.
(E) In addition to exchange reactions, the biomass objective function acts as a
drain on cellular components in the same ratios as they are experimentally
measured in the biomass. In FBA simulations, the biomass function is used to
simulate cellular growth. The biomass function is composed of all necessary
compounds needed to create a new cell, including DNA, amino acids, lipids,
and polysaccharides. This is not the only physiological objective that can be
examined using COBRA tools.
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equations given the governing constraints. FBA uses the
stated objective to find the solution(s) that optimize the
objective function. The solution is found using linear program-
ming, and, as indicated in Figure 2C, the optimal solution lies
at the edges of the solution space impinging up against govern-
ing constrains.
The utility of FBA has been increasingly recognized due to its
simplicity and extensibility: it requires only the information on
metabolic reaction stoichiometry and mass balances around
the metabolites under pseudo-steady state assumption. It com-
putes how the flux map must balance to achieve a particular
homeostatic state. However, FBA has limitations. It balances
fluxes but cannot predict metabolite concentrations. Except
in some modified forms, FBA does not account for regulatory
effects such as activation of enzymes by protein kinases or
regulation of gene expression. More details are found in the
caption of Figure 2, and computational resources are summa-
rized below that can be deployed to find the optimal state and
to study its characteristics.
Models Impose Constraints and Allow Prediction
One of the most basic constraints imposed on genome-scale
models of metabolism is that of substrate, or nutrient, availability
and its uptake rate (Figure 2D). Metabolites enter and leave the
systems through what are termed ‘‘exchange reactions’’ (i.e.,
active or passive transport mechanisms). These reactions define
the extracellular nutritional environment and are either left
‘‘open’’ (to allow a substrate to enter the system at a specified
rate) or ‘‘closed’’ (the substrate can only leave the system).
Measurements of the rate of exchange with the environment
are relatively easy to perform, and they prove to be some of
the more important constraints placed on the possible functions
of reaction networks internal to the cell. More biological- and
data-derived constraints can also be imposed on amodel. These
advanced constraints are detailed in sections 4, 5 and 6.
The next step in converting a network reconstruction to a
model is to define what biological function(s) the network can
achieve. Mathematically, such a statement takes the form of
an ‘‘objective function.’’ For predicting growth, the objective is
biomass production—that is, the rate at which the network can
convert metabolites into all required biomass constituents
such as nucleic acids, proteins, and lipids needed to produce
biomass. The objective of biomass production is mathematically
represented by a ‘‘biomass reaction’’ that becomes an extra
column of coefficients in the stoichiometric matrix. One can
formulate a biomass objective function at an increasing level of
detail: basic, intermediate, and advanced (Feist and Palsson,
2010; Monk et al., 2014). The biomass reaction is scaled so
that the flux through it represents the growth rate (m) of the target
organism.
It is important to note that the biomass objective function is
determined from measurements of biomass composition—the
uptake and secretion rates from measuring the nutrients in the
medium—and that the model formulation is built on a knowl-
edge-based network reconstruction. Thus, the growth rate
optimization problem represents ‘‘big data’’ integrated into a
structured format and the hypothesis of a biological objective:
grow as fast as possible with the resources available. This is a
well-defined optimization problem.
GEMs Are Input-Output ‘‘Flow Models’’
The inner workings of a GEM are readily understood conceptu-
ally. In a given environment (i.e., where the nutritional inputs
are defined) GEMs can be used to compute network outputs.
FBA can computationally trace a fully balanced path through
the reactome from the available nutrients to the prerequisite
output metabolite. Such calculations are performed with an
objective function that describes the removal of the target
metabolite from the network. The synthesis of biomass in a cell
requires the simultaneous removal of about 60–70 different me-
tabolites. Using FBA, a GEM can also compute the balanced use
of the reactome to produce all of the prerequisite metabolites for
growth simultaneously and does so in the correct relative
amounts while accounting for all of the energetic, redox, and
chemical interactions that must balance to enable such biomass
synthesis. This exercise is one of genome-scale accounting of all
molecules flowing through the reactome.
Recapitulation
Given its simplicity and utility, FBA has become one of the most
widely employed computational techniques for the systems-
level analysis of living organisms (Bordbar et al., 2014; Lewis
et al., 2012). It has been successfully applied to a multitude of
species for modeling their cellular metabolisms (Feist and Pals-
son, 2008; McCloskey et al., 2013; Oberhardt et al., 2009) and
therefore enabled a variety of applications such as metabolic
engineering for the over-production of biochemicals (Yim et al.,
2011; Adkins et al., 2012), identification of anti-microbial
drug targets (Kim et al., 2011), and the elucidation of cell-cell
interactions (Bordbar et al., 2010). Further reading and detailed
descriptions of FBA and sources for existing genome-scale
models are available in Table S1.
3. Validation and Reconciliation of Qualitative
Model Predictions
Ensuring the consistency and accuracy of all of the information
available for a target organism is a grand challenge of
genome-scale biology. Since model predictions are based on
a network reconstruction that represents the totality of what is
known about a target organism, such predictions are a critical
test of our comprehensive understanding of the metabolism for
the target organism. Incorrect model predictions can be used
for biological discovery by classifying them and understanding
their underlying causes. Performing targeted experiments to
understand failed predictions is a proven method for systematic
discovery of new biochemical knowledge (Orth and Palsson,
2010b). This section will focus on evaluating qualitative model
predictions, their outcomes, underlying causes of incorrect
predictions, and how to go about correcting them. Section 4
discusses the same process for quantitative model predictions.
Genetic and Environmental Parameters
Genome-scale models have many genetic and environmental
parameters that can be experimentally varied. Altering the
composition of the growth media changes environmental pa-
rameters. Alteration of genetic parameters is achieved through
genome editing methods. Both environmental and genetic pa-
rameters are explicit in GEMs, and thus the consequence of
both types of perturbations can be computed, predicted, and
analyzed. The scale of such predictions has grown steadily since
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the first genome-scale model of E. coli appeared in 2000 (Ed-
wards and Palsson, 2000).
Genome-scale gene essentiality data are available from
specific projects or organism-specific databases. One can sys-
tematically remove genes from a reconstruction and thus the
corresponding reactions from the reactome and then repeat
the growth computation to predict gene essentiality; if a growth
state cannot be computed without a particular gene, the GEM
predicts it to be essential (Figure 3A). Such growth rate predic-
tions of gene deletion strains have gone from 100 predictions
in the year 2000 (Edwards and Palsson, 2000) to more than
100,000 in 2013 (O¨sterlund et al., 2013) and may be heading
for more than one million predictions in just a few years (Monk
and Palsson, 2014).
Both environmental and genetic parameters can be varied
when performing FBA. The simplicity of computing growth states
(i.e., an output) as a function of media composition (i.e., the nutri-
tional inputs) with the selective removal of genes (Figure 3B) has
led to a number of studies that cross environmental parameters
with gene deletions. The explicit relationship between a gene
and a reaction makes the deletion of genes and their encoding
reactions straightforward. You can readily do this for your target
organism, provided that you can construct a library of gene dele-
tion strains. Improved molecular tools for generating knockout
collection libraries (Tn-seq, CRISPR systems, etc.) and improved
high-throughput methods for measuring knockout phenotypes
have enabled a massive scale-up in the number of phenotypes
that can be measured.
Classification of Model Predictions
Computational predictions of outcomes fall into four categories:
true positives, true negatives, false positives, and false nega-
tives. The true-positive and true-negative predictions, in which
computational predictions and experimental outcomes agree,
have generally exceeded 80%–90% for well-characterized
target organisms. Going beyond single-gene knockouts to
double-gene knockouts and more, true-negative predictions
are particularly significant, as they indicate model predictions
of true genetic, or epistatic, interactions. In a screen of double-
gene yeast knockouts, Szappanos et al. found that models could
predict 2.8% of negative genetic interactions (Szappanos et al.,
2011). While this indicates poor recall of prediction, of these,
50% were correct, indicating that model predictions are highly
precise but may miss several interactions. These missed predic-
tions represent cases that are currently difficult for functional
geneticists to understand. For applications where the goal is to
have true predictions, such as for antibiotic design, precision is
more important than recall.
FBA-based models are highly precise because they are
good at predicting impossible states (such as when a gene
knockout leads to death). This assumes that the network struc-
ture is complete, an assumption that can be a problem when
promiscuous enzyme activity arises, leading to a reaction with
an encoding gene that is not captured in the model. Models
have lower accuracy because FBA assumes that all reactions
can happen at maximum rates. Model false positives often
occur because an enzyme is either transcriptionally repressed
or does not catalyze the designated reaction at a high enough
rate (Table S2). Predictive failure is perhaps of more interest
than success, as it represents an opportunity for biological dis-
covery. False-negative predictions occur when a GEM predicts
the inability to grow in a given environment without the deleted
gene, but the experiments show growth. This discrepancy indi-
cates that the reconstructed reactome is incomplete. In contrast,
false-positive predictions occur when a GEM predicts growth
but the experiment results in no growth. This outcome indicates
possible errors in the knowledge on which the reactome was
based or that a regulatory process is missing that prevents the
use of a gene product factored in the computed solution.
An example would be regulation that either represses gene
expression or a metabolite-enzyme interaction that inhibits the
function of an enzyme that the GEM used to compute the pre-
dicted growth state.
Prediction failures can be used to systematically (i.e., algorith-
mically) generate hypotheses addressing the failures. Such
hypotheses have been shown to direct experimentation to
improve our knowledge base for the target organism. Computa-
tions that vary environmental and genetic parameters become
part of a workflow (Figure 3C). The outcome of the workflow is
a set of qualitative model predictions of growth or no growth
that are then compared to the experimental outcome of a growth
screen. Correct predictions align with experimental results,
while incorrect predictions do not. The two are then compared
and classified into four categories, as shown in Figure 3C. The
failure modes lead to systematic experimentation.
Discovery Using Model False Negatives
Reconciling such discrepancies between predicted and
observed growth states is now a proven approach for biological
discovery. A series of algorithms have been developed that have
been shown to compute the most likely reasons for failure of
prediction that, in turn, led to a model-guided experimental
inquiry and discovery. Furthermore, high-throughput tools
such as phenotypic microarrays and robotic instruments are
becoming available to screen cells at high rates. Such discov-
eries are then incorporated into the reconstruction, leading to
its iterative improvement.
The discrepancies between GEM predictions and experi-
mental data have been used to design targeted experiments
that correct inaccuracies in metabolic knowledge. In this
subsection, we provide three illustrative examples that detail
how reconciliation of model errors led to the discovery of new
metabolic capabilities in three model organisms (Figure 3D).
Human. The activity of open reading frame 103 on chromo-
some 9 (C9orf103) of the human genome was discovered
(Rolfsson et al., 2011a) using established gap-filling protocols
(Orth and Palsson, 2010b; Reed et al., 2006). The authors
focused on unconnected, ‘‘dead-end’’ metabolites in the human
metabolic network reconstruction, Recon 1 (Duarte et al., 2007).
Dead-end metabolites lead to model errors by creating blocked
reactions due to a violation of mass balance. Any flux leading
to them cannot leave the network. In an attempt to connect
these dead-end metabolites, a universal database of metabolic
reactions was used to predict the fewest reactions required
to fully connect all metabolites in the network. Focusing on
gluconate, which is a disconnected metabolite, the authors
experimentally characterized C9orf103, previously identified as
a candidate tumor suppressor gene, as the gene that encodes
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Figure 3. Using Models for Qualitative Predictions and Iterative Improvement
(A) Each reaction in the network is linked to a protein and encoding gene through the gene-protein-reaction (GPR) relationship. Because each reaction in the
network corresponds to a column in the stoichiometric matrix, simply removing the column association with a particular reaction can simulate gene knockouts.
Thus, multiple KO simulations can be performed. For example, it is easy to delete every pairwise combination of 136 central carbonmetabolic E. coli genes to find
double-gene knockouts that are essential for survival of the bacteria.
(B) The simplicity of altering inputs to change cellular growth environments and removing genes in silico allows one to perform simulations in millions of
experimental conditions quickly. Even on a modest laptop computer, a single FBA calculation runs in a fraction of a second, thus simulating the effect of all gene
knockouts in E. coli central metabolism in less than 10 s.
(C) Incorrect model predictions are an opportunity for biological discovery because they highlight where knowledge is missing. Targeted experiments can
be performed to discover new content that can then be added back to a model to improve its predictive accuracy. Missing model content can be discovered
using automated approaches known as ‘‘gap filling’’ (Orth and Palsson, 2010a) that query a universal database of potential reactions to restore in silico growth
to a model.
(legend continued on next page)
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gluconokinase, thereby consuming this metabolite and connect-
ing it to the rest of the human metabolic network.
E. coli. Gap-filling methods combined with systematic gene
knockouts in E. coli (Nakahigashi et al., 2009b) were used to
discover new metabolic functions for the classic glycolytic en-
zymes phosphofructokinase and aldolase. Single-, double-,
and triple-knockout strains of central metabolic genes were
grown on 13 different carbon sources. Concurrently, the same
gene knockouts and growth conditions were simulated using
the E. coli GEM. Several discrepancies between model predic-
tions and experimental results were related to talAB interactions
in the pentose phosphate pathway and could not be reconciled.
A metabolomic analysis identified a new metabolite, sedoheptu-
lose-1,7-bisphosphate, that had not been previously character-
ized. Using metabolic flux analysis and in vitro enzyme assays,
the investigators confirmed that phosphofructokinase carries
out the reaction and that glycolytic aldolase can split the
seven-carbon sugar into three- and four-carbon sugars, glycer-
aldehyde-3-phosphate (G3P) and D-erythrose 4-phosphate
(E4P), respectively.
Yeast. An analysis of synthetic lethal screens and gap-filling
methods was used to correct incorrect pathways leading to
NAD+ synthesis in yeast (Szappanos et al., 2011). The study
compared an experimental set of genetic interactions for
metabolic genes against interactions that were predicted by
FBA. Using machine-learning techniques, key changes to the
metabolic network that improved model accuracy were identi-
fied. Model refinement identified one of the two NAD+ biosyn-
thetic pathways from amino acids in the GEM as a source of
inaccurate predictions. Using growth screens with mutant
strains, the authors validated that the synthesis of NAD+ from
amino acids was only possible from L-tryptophan (L-trp), but
not from L-aspartate (L-asp).
Adaptive Laboratory Evolution in the Discovery Process
In contrast to false negatives, false positives arise when the
model predicts growth, but experiments show no growth
(Figure 3E). False positives occur in cases in which experimental
data show a particular gene to be essential but model simula-
tions do not. Metabolic models can be used to predict efficient
compensatory pathways, after which cloning and overexpres-
sion of these pathways are performed to investigate whether
they restore growth and to help determine why these compensa-
tory pathways are not active in mutant cells.
Discovering Context-Specific Regulatory Interactions Using
False-Positive Predictions. Cloning and overexpression of a
false-positive associated gene has been demonstrated for a
ppc knockout of Salmonella enterica serovar Typhimurium
(Fong et al., 2013). A metabolic model of S. Typhimurium pre-
dicted that the cells could route flux through the glyoxylate shunt
when ppc is removed due to the backup function of isocitrate
lyase encoded by aceA. However, theDppc cells were nonviable
experimentally. The protein IclR is a transcription factor that
regulates the transcription of genes involved in the glyoxylate
shunt, including aceA. Therefore a dual-knockout DppcDiclR
mutant was constructed. Growth was restored in this double
mutant at 60% of the wild-type growth rate. Therefore, the
prediction of the metabolic model of S. Typhimurium failed
because it erroneously allowed flux through the glyoxylate
shunt when ppc was deleted due to the absence of regulatory
information in the model.
Adaptive laboratory evolution can also be used to reconcile
false-positive predictions. Often, cell populations may need
time to adapt to a genetic change or shift in media conditions,
giving them the appearance of slow or no growth despite a
model prediction of growth. However, it has been shown that
incorrect predictions of in silico models based on optimal per-
formance criteria may be incorrect due to incomplete adaptive
laboratory evolution under the conditions examined. It has been
shown that E. coli K-12 grown on glycerol over 40 days
(or about 700 generations) and subjected to a growth rate
selection pressure (passing a small fraction of the fastest
growers) achieves a final growth rate that is predicted by the
GEM (Ibarra et al., 2002). The quantitative prediction of growth
rates is discussed in section 4. Thus, a false-positive result may
indicate that the model is in fact correct, and a researcher
should be patient while the cell adapts to achieve the model-
predicted growth.
Recapitulation
Given that our knowledge of any target organism is incomplete,
its network reconstruction will also be incomplete. Thus, failures
in GEM prediction of qualitative outcomes of growth capability
are informative about the completeness of a network reconstruc-
tion and the consistency of its content. Furthermore, these
approaches can be extended beyond model improvement. As
genome editing techniques improve, in silico prediction of the
effect of multiple gene knockouts will be vital for contextualizing
results of knockout studies and engineering genomes to achieve
a desired phenotype (Campodonico et al., 2014). Additionally,
reconciliation of model false negatives has been used to explore
the role that underground metabolism plays in adapting to
alternate nutrient environments (Notebaart et al., 2014). The
algorithmic procedures that have been developed to address
failure of prediction have led to some computer-generated
hypotheses resulting in productive experimental undertaking.
Further reading about the gap-filling process and algorithms
for its implementation are available in Table S1.
(D) Gap-filling approaches have been used to discover new metabolic reactions in several organisms. E. coli: Two new functions for two classical glycolytic
enzymes, phosphofructokinase (PFK) and fructose-bisphosphate aldolase (FBA), were discovered (red) (Nakahigashi et al., 2009a). Human: Gluconokinase
(EC 2.7.1.12) activity was discovered based on the known presence of the metabolite 6-phosphogluconolactonate in the human reconstruction (Rolfsson et al.,
2011b) (red). Yeast: Automated model refinement suggested modifications in the NAD biosynthesis pathway. Experiments demonstrated that a parallel pathway
from aspartate thought to exist in yeast was not present (Szappanos et al., 2011).
(E) False-positive predictions can be reconciled by adding regulatory rules derived from high-throughput data (Covert et al., 2004), for example, a recent study
was able to reconcile 2,442 false-model predictions from the E. coli GEM by updating the function of just 12 genes (Barua et al., 2010). Additionally, a false-
positive growth inconsistency in the metabolic model of S. Typhimurium was reconciled by updating regulatory rules for the iclR gene product’s transcriptional
repression of aceA encoding isocitrate lyase. Transcriptional repression can also often be relieved via adaptive laboratory evolution. Such evolution drives
experimental phenotypes to achieve model predictions. Several experimental studies have shown that an organism can evolve to achieve the model-predicted
optimal growth state (Ibarra et al., 2002).
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4. Quantitative Phenotype Prediction throughOptimality
Principles
The previous section treated qualitative predictions that relate
to the presence or absence of parts from a reconstruction.
Quantitative predictions of phenotypic functions are more chal-
lenging but possible. The ability to compute quantitative organ-
ism functions from a genome-scale model represents a grand
challenge in systems biology. Quantitative predictions are
achievable with GEMs (even if they are based on incomplete
reconstructions) by deploying cellular optimality principles.
Evolutionary arguments underlie the deployment of optimality-
based hypotheses. Phenotypes maximizing a hypothesized
fitness function (as represented by an objective function) can
be computed with constrained-optimization methods (Orth
et al., 2010).
As for qualitative binary predictions of possible growth states,
incorrect quantitative predictions often lead to new biological
hypotheses and understanding. However, the discoveries
arising from quantitative phenotype predictions are typically of
a different nature than qualitative predictions. Rather than
relating tomissing reconstruction content (section 3), the discov-
eries from quantitative phenotype prediction often relate to
broad, fundamental organismal constraints (Beg et al., 2007;
Zhuang et al., 2011b) and evolutionary objectives and trade-
offs (Shoval et al., 2012).
Quantitative phenotype prediction has also proven to be
a useful capability for bioengineering applications. By opti-
mizing an engineering (instead of evolutionary) objective,
the best possible performance of an engineered biological sys-
tem can be determined. Furthermore, the specific flux states
needed to achieve high performance can guide engineering
design.
Workflow for Quantitative Phenotype Prediction
Quantitative phenotypes can be predicted through the same
computational procedures used for qualitative growth predic-
tions (Figure 4A). An objective (either evolutionary or engineer-
ing) is assumed and maximized computationally (subject to
flux balance and other constraints). The flux state(s) that
maximize the objective are then the predicted quantitative
fluxes. These predictions can then be compared to experi-
mental measurements. In cases of agreement, the evolu-
tionary hypothesis is supported. In cases of a disagreement
between experimental and theoretical predictions, either the
biological system has not been exposed to the selection
pressure to reach the theoretical optimum (i.e., the assumed
evolutionary objective is incorrect or partially correct) or
there are missing biological constraints that affect the theoret-
ical predictions (i.e., the relevant biological constraints are
incomplete).
Experimental evolution can discriminate between these alter-
natives (Ibarra et al., 2002; Schuetz et al., 2012) by exposing the
biological system to the appropriate selection pressure, leading
it to evolve toward the stated optimum. For example, in one
study, strains carrying deletions of one of six metabolic genes
were evolved on four different carbon sources. A total of 78%
of strains tested reached the metabolic model predicted optimal
growth rate after adaptive laboratory evolution after 40 days of
passage (Fong and Palsson, 2004).
Flux Variability Analysis Calculates Possible Flux States
Flux balance analysis computes an optimal objective value and
a flux state that is consistent with that objective (and all of
the imposed constraints). While the objective value is unique,
multiple flux states can typically support the same objective
value in genome-scale models. For this reason, flux variability
analysis (FVA) is used to determine the possible ranges for
each reaction flux (Mahadevan and Schilling, 2003). With FVA,
the objective value is set to be equal to its maximum value,
and each reaction is maximized and minimized. For some
fluxes, their maximum value will be equal to their minimum,
enabling a specific prediction. For others, there may be a
wide range of possible values due to alternative pathways.
Often, a parsimonious flux state is also assumed and computed
with parsimonious FBA (pFBA) (Lewis et al., 2010a). With pFBA,
the sum of fluxes across the entire network is minimized
(again, subject to the optimal objective value determined);
pFBA will eliminate some alternative pathways. Typically,
many reaction fluxes can be uniquely predicted with optimality
and parsimony assumptions. Additional biological constraints in
next-generation models (section 6) reduce the possible flux
states further (Lerman et al., 2012).
Types of Possible and Evolutionarily Optimal
Quantitative Predictions
The simplest type of quantitative phenotype predictable with
constraint-based models is nutrient utilization. While metabolic
models do not predict absolute rates of nutrient uptake, they
predict the optimal ratios at which nutrients are utilized. For
example, metabolic models predict an optimal oxygen uptake
rate relative to the carbon source uptake rate (resulting in a pre-
dicted optimal ratio between the two nutrients). In an early
study, the ratios of oxygen and carbon uptake were shown to
be predictable for a number of carbon sources in E. coli
(Edwards et al., 2001). In a later study, E. coli was evolved in
the laboratory on a carbon source (glycerol) for which the
wild-type strain did not match the predicted nutrient utilization;
after evolution, the strain exhibited the optimal uptake rates
predicted theoretically (Figure 4B) (Ibarra et al., 2002). Compar-
ison of experimental and predicted phenotypes therefore
reveals the environments to which an organism has been evolu-
tionary exposed.
Metabolic fluxes for central carbon metabolism can be esti-
mated with 13C carbon labeling experiments, making them
candidates for quantitative prediction (Figure 4B). Since the
dimensionality of carbon labeling data is larger than that for
nutrient uptake, there is more opportunity to dissect the differ-
ences in computed and measured fluxes to better understand
the multiple objectives and constraints underlying microbial
metabolism. Impressively, the biomass objective function can
explain a large amount of the variability of fluxes (Schuetz
et al., 2007). Failure modes in prediction have led to the appreci-
ation of the importance of protein cost (O’Brien et al., 2013) and
membrane (Zhuang et al., 2011b) and cytoplasmic spatial con-
straints (Beg et al., 2007), which affect the optimal flux state
(Figure 4C). Furthermore, failure modes have led to the under-
standing that metabolism is simultaneously subject to multiple
competing evolutionary objectives, resulting in trade-offs (e.g.,
growth versus maintenance) employed by different species
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(Figure 4C). In this way, outliers in quantitative predictions can
improve the understanding of constraints and objectives under-
lying a particular organism’s metabolism.
Optimality principles from stoichiometric models have also
been expanded from single populations of cells to microbial
communities. To model microbial communities, multiple species
are linked together through the exchange of nutrients extra-cell-
ularly (Stolyar et al., 2007) or through direct electron transfer
(Nagarajan et al., 2013). The secretion rate from one species
limits the uptake rate for others, resulting in balanced species
interactions. For a number of cases of communities composed
of two or three members, the optimal rate of nutrient exchange
and the ratio of the species in the population (Wintermute and
Silver, 2010) can be predicted. The effects of spatial organization
of community members are also being uncovered (Harcombe
et al., 2014). The constraints on nutrient flow between organisms
(e.g., diffusion) have proven to be important for predicting com-
munity composition and behavior, highlighting the importance
of abiotic constraints and community structure in the behavior
of biological communities.
Figure 4. Quantitative Phenotype Prediction
Using Optimization
(A) Quantitative phenotype prediction is an
iterative workflow. First, hypothesized biological
constraints and objectives are formulated
mathematically, and computational optimization
is used to determine optimal phenotypic states
(see section 2). The predicted phenotypic
states can then be compared to experimental
measurements to identify where predictions
are consistent. When consistent, the hypothe-
sized evolutionary objective and constraints are
validated. When inconsistent, laboratory evolu-
tion can be used to gain further insight as to
why the computed and measured states differ.
Examples of validation of quantitative pheno-
types are detailed in (B), and further hypotheses
derived from incorrect predictions are detailed
in (C).
(B) The generic workflow in (A) has been
successfully applied to several classes of phe-
notypes. (1) Nutrient utilization ratios can be
predicted by maximizing biomass flux (Edwards
et al., 2001). (2) Central carbon metabolism fluxes
can be predicted; for some organisms, much of
the variability in flux can be attributed to biomass
flux maximization (Schuetz et al., 2012). (3) The
ratio of organism abundances and nutrient ex-
changes can be predicted for both natural and
synthetic communities. Note that one important
feature of quantitative phenotype predictions is
that optimal flux solutions are often not unique.
To address this, flux variability analysis (FVA)
(Mahadevan and Schilling, 2003) can be used to
identify the ranges of possible fluxes. It should be
noted that non-uniqueness is not necessarily a
handicap of COBRA, as biological evolution can
come up with alternate solutions (Fong et al.,
2005).
(C) Inconsistencies with model predictions
have led to the appreciation of new constraints
and objectives underlying cellular phenotypes.
(1) Inconsistent predictions in by-product
secretion have led to the hypothesis that
membrane space limits membrane protein
abundance and metabolic flux (Zhuang et al.,
2011b). (2) The range of metabolic fluxes
observed across different environments has led
to the realization that fluxes can be understood
as simultaneously satisfying multiple competing
objectives, such as growth and cellular mainte-
nance. Multi-objective optimization algorithms
find solutions that maximize multiple competing
objectives.
(D) Accurate prediction of quantitative pheno-
types has led to prospective design of biological
functions. A number of algorithms have been
developed that predict genetic and/or environ-
mental perturbations required to achieve a bioengineering objective. Relevant bioengineering objectives have included biosensing, bioremediation, bio-
production, the creation of synthetic ecologies, and the intracellular production of reaction oxygen species (ROS) to potentiate antibiotic effects.
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Figure 5. Data Integration and Exploration of Possible Cellular Phenotypes
(A) The general workflow formulti-omic data integration begins with the conversion of the experimental data intomodel constraints (see B). This procedure results
in cell-type- (e.g., neuron, macrophage) and condition-specific (e.g., healthy versus diseased) models that represent the metabolic capabilities of those specific
cells (see C). Several computational procedures can then be used to explore the metabolic capabilities and determine achievable phenotypes systematically (see
D). Evaluation of these phenotypic capabilities and comparison of different cells or environments leads to identification of their molecular differences (see E).
Additionally, if the original experimental data cannot precisely distinguish between certainmetabolic states, additional targeted experiments can be designed and
integrated as further constraints.
(B) Numerous data types can be integrated into metabolic models. Some directly affect model structure and variables (e.g., growth rate, biomass composition,
exchange fluxes, internal fluxes, and reaction directionality). Standard processing of these data types allows for integration into themodel. Other data types affect
metabolic fluxes more indirectly. As such, different computational methods exist for formulating the appropriate constraints (Table S1).
(C) Experimental data are integrated to construct cell-type- and/or condition-specificmodels. Thesemodels represent themetabolic capabilities in a certain state
and are then used for further inquiry (see D and E). Specific algorithms for building cell-type-specific models from gene expression data include MBA (Jerby et al.,
2010) and GIMME (Becker and Palsson, 2008).
(legend continued on next page)
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Evolution is a natural counterpart to optimality-based predic-
tions with constraint-based methods. Constraint-based opti-
mality predictions have focused on predicting the endpoints of
short-term experimental evolution. However, this scope of appli-
cation has increased in recent years to study long-term pheno-
typic and enzyme evolution (Nam et al., 2012; Plata et al., 2015).
From Optimality Principles to Prospective Design
Quantitative phenotype prediction via optimization is also
commonly used for bioengineering applications (Figure 4D).
For example, in metabolic engineering, optimal pathway yields
are used to prioritize pathways to be built into a production strain
and to benchmark their performance. Furthermore, the flux
states required to achieve these optima (and how they differ
from wild-type growth states) can guide strain design (Cvijovic
et al., 2011).
A number of design algorithms have been built to work with
metabolic models and predict the genetic and environmental
modifications to increase performance (Burgard et al., 2003;
Ranganathan et al., 2010). While many design algorithms and
applications have been focused on metabolite production (e.g.,
for production of fuels and chemicals), metabolic models have
also been utilized for the design of biosensors (Tepper and
Shlomi, 2011) and biodegradation (Scheibe et al., 2009; Zhuang
et al., 2011a). Also, design has expanded beyond single popula-
tions to microbial communities/ecosystems (Klitgord and Segre`,
2010).
Recapitulation
Quantitative phenotype predictions initially focused on simple
physiological predictions and are still expanding to more com-
plex phenotypes, biological systems (Levy and Borenstein,
2013), and environments. Although there have been notable suc-
cesses of quantitative phenotype prediction, certain phenotypes
are still difficult to predict. Historically, difficult predictions have
led to the development of new computational methods and an
appreciation of new biological constraints. Table S2 summarizes
several types of predictions and the approximate performance of
constraint-based methods utilized to date. The expansion in the
scope and accuracy of predictions continues today, with models
of increased scope (Chang et al., 2013a; O’Brien et al., 2013),
discussed in section 6.
Thus far, quantitative phenotypes have been limited primarily
to microbial systems and, more recently, plants (Collakova
et al., 2012; Williams et al., 2010). For multi-cellular organisms,
specialized cell types support the fitness of the entire organism.
Cell-type-specific ‘‘objectives’’ have been constructed (Chang
et al., 2010), though they typically are used for qualitative (sec-
tion 3) rather than quantitative phenotype prediction. Instead,
quantitative phenotypes in multi-cellular organisms are typically
determined through model-driven analysis of experimental data,
discussed in section 5.
5. Multi-Omic Data Integration: Constraining
and Exploring Possible Phenotypic States
With the expanding quantity of omics and other phenotypic data,
there is an increasing need to integrate these data sets to drive
further understanding and hypothesis generation. Phenotypic
data types can be integrated with metabolic GEMs to determine
condition-specific capabilities and flux states in the absence of
assumed objectives (section 4). Computational methods that
identify the possible range of phenotypic states given the
measured data allow one to quantify the degree of (un)certainty
in metabolic fluxes. Some types of data are quantitative and
directly indicative of metabolic fluxes, whereas other data are
qualitative or indirectly related to metabolic fluxes. By layering
different data types, the true state of a biological system can
be determined with increased precision. The need for formal
integration of disparate data types represents a grand challenge
that has been termed Big Data to Knowledge (BD2K, http://
bd2k.nih.gov).
Workflow for Multi-omic Data Integration
The overall procedure for multi-omic integration with genome-
scale models is an iterative workflow (Figure 5A). Once experi-
mental data from the particular biological system under study
is obtained, it is converted into constraints on model function
(Figure 5B). The successive application of experimentally
derived constraints to the reaction network results in the gener-
ation of a cell-type- and condition-specific model (Figure 5C).
Several computational procedures can then be used to explore
the metabolic capabilities and achievable phenotypes of the
experimentally constrained model (Figure 5D). Evaluation of
these phenotypic capabilities and comparison of different cells
or environments lead to identification of their molecular differ-
ences (Figure 5E), providing biological insight and driving further
hypotheses.
Converting Data to Model Constraints
Successive imposition of constraints is a basic principle of
COBRA (Palsson, 2000). Some data types can be directly con-
verted into constraints on model variables. Biomass composi-
tion and growth rate affect the metabolic demands of cellular
growth (Feist and Palsson, 2010). Time-course exo-metabolo-
mics can be used to set the uptake and secretion rates of nutri-
ents (Mo et al., 2009). Intracellular quantitative metabolomics
combined with reaction free energies can discern condition-
specific reaction directionalities (Henry et al., 2007). Isotopomer
distributions from cellular biomass or metabolite pools can be
used to infer and constrain intracellular fluxes (Zamboni et al.,
2009). These data can be used separately or combined to iden-
tify with increasing precision the true state of the cell.
Other data types affect metabolism more qualitatively. In the-
ory, quantitative metabolite, transcript, and protein levels can be
used to constrain metabolism quantitatively, but in practice,
(D) After adding constraints to the model, computational procedures are used to assess the implication of the experimental data on metabolic fluxes. The two
main methods for querying the consequences of the measured data on a cell’s phenotypes are flux variability analysis (FVA) and Markov-chain Monte-Carlo
(MCMC) sampling. (1) FVA determines the maximum and minimum values of all metabolic fluxes. (2) MCMC sampling randomly samples feasible metabolic flux
vectors (usually resulting in tens to hundreds of thousands of flux vectors). These sampled flux vectors can then be used to derive the distribution of possible flux
values for a given metabolic reaction.
(E) Often a comparative approach is employed in which experimental data from two conditions are used to generate two condition-specific models. Then, the
achievable phenotypes of the two states are compared (e.g., though MCMC sampling, see D).
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this requires many parameters that are hard to measure and are
organism specific. Instead, these data types can be used as
qualitative constraints relating to gene product or metabolite
presence/absence; that is, if a metabolite is present, a reaction
must be active that produces it (Shlomi et al., 2008), and if a
gene product is absent, its catalyzed reactions cannot carry
flux (Jerby et al., 2010; Schmidt et al., 2013). Similarly, regulatory
interactions can be added to affect the presence/absence of
a gene product based on condition-specific activity of a tran-
scription factor (Chandrasekaran and Price, 2010).
Cell-Type- and Condition-Specific Models
Starting from a large reconstructed reaction network (e.g., repre-
senting all metabolic reactions encoded in the human genome
[Thiele et al., 2013]), the imposition of experimental data results
in the generation of cell-type- and condition-specific models.
Experimentally derived constraints pare down the achievable
phenotypes from those encoded by the totality of the cell’s
genome. By eliminating phenotypes that cannot be achieved,
this new model represents the capabilities of the particular cell
type and environment assayed. This model summarizes the
experimental data in a self-consistent and integrated format
and forms the starting point for further computational and biolog-
ical inquiry (Agren et al., 2012; Shlomi et al., 2008) (see Figures
5D and 5E).
Quantifying Uncertainty
Once a cell-type- and condition-specific model is created,
computational methods are used to determine the possible
flux states of the cell. FVA (which is described in section 4)
(Mahadevan and Schilling, 2003) can be used to determine the
range of fluxes that are consistent with the experimental data.
A more refined approach is flux sampling (Schellenberger and
Palsson, 2009) (typically with Markov Chain Monte Carlo
[MCMC] methods), which determines the distribution of fluxes
for all reactions (instead of simply the range). When no cellular
objective is assumed, the feasible flux space is very uncon-
strained and a particular reaction could be operating at nearly
any flux value. As more data are layered, the feasible flux space
decreases. When no objective is assumed, fluxes are rarely
precisely known, and many will remain completely unknown.
However, an imprecisely known flux space is often sufficient
to discern differences between two environments/states as
discussed in the following subsection.
Using Computed States to Drive Discovery
Once the range of possible phenotypic states is quantified, they
must be analyzed to gain biological insights. Often a compara-
tive approach is employed, in which two experimental states
(e.g., neurons from Alzheimer’s disease patients compared to
healthy controls [Lewis et al., 2010b]) are compared. Reactions
that have a non-overlapping FVA range must be different be-
tween the two states and can be indicative of important meta-
bolic changes. In cases in which the FVA ranges are overlapping,
the flux distributions from MCMC sampling can still be different;
that is, the reactions are likely different between the two states,
but the current experimental data are insufficient to guarantee it.
Pathway visualization is also helpful in gaining insight into
changes in cell states—fluxes (or flux ranges) are most com-
prehensible in a network context. A few tools exist for the visual-
ization of metabolic fluxes; some are based on static maps
(Schellenberger et al., 2010), whereas others create auto-gener-
ated layouts and new tools allow for the drawing of maps based
on flux solutions (King and Ebrahim, 2014). Finally, identifying
reactions or subsystems that remain partially identified (e.g.,
based on a large FVA range) can guide further experimentation,
resulting in an iterative computational and experimental elucida-
tion of a cell’s state.
Recapitulation
GEMs can be used to integrate numerous data types. In fact,
as more experimentally derived constraints are successively
imposed, analysis often becomes easier (as the range of
possible solutions shrinks [Reed, 2012]) instead of more chal-
lenging, as often occurs with statistically based data integration
procedures. A current challenge with metabolic GEMs is the
explicit integration of data types that do not directly reflect meta-
bolic fluxes (e.g., transcriptomics, proteomics, and regulatory
interactions). This challenge is primarily due to the fact that
these processes are not explicitly described in metabolic
models. Expansion of metabolic models to encompass gene
expression hold promise to address this challenge and are
discussed in section 6.
6. Moving beyond Metabolism to Molecular Biology
Up to this point, this Primer has focused on metabolic models,
or M models. M models have reached a high degree of sophisti-
cation after 15 years of development, resulting in standard
operating procedures for their construction (Thiele and Palsson,
2010) and use (Schellenberger et al., 2011a). However, M
models are limited in their explicit coverage to metabolic fluxes.
Thus, a grand challenge in the field has been to expand the con-
cepts of constraint-basedmodels of metabolism to other cellular
processes to formally include more disparate data types in
genome-scale models (Reed and Palsson, 2003).
Computing Properties of the Proteome
The process of addressing this grand challenge has begun
(Figure 6A). Recently, genome-scale network reconstructions
have expanded to encompass aspects of molecular biology.
Two significant expansions are genome-scalemodels integrated
with protein structures, GEM-PRO, and integrated models of
metabolism and protein expression, ME models. GEM-PRO al-
lows for structural bioinformatics analysis to be performed
from a systems-level perspective and to have those results in
turn affect network simulations. ME models allow for the simula-
tion of proteome synthesis and account for the capacity and
metabolic requirements of gene expression.
A Structural Biology View of Cellular Networks
GEM-PRO reconstructions can have varying degrees of detail,
which affects the types of analysis possible. So far, GEM-PRO
reconstructions have been created for T. maritima (Zhang
et al., 2009) and E. coli (Chang et al., 2013a; Chang et al.,
2013b). Initial reconstructions have focused on single peptide
chains (Zhang et al., 2009) and have utilized homology modeling
to fill in gaps where organism-specific structures have not been
identified. Further reconstruction detail has included protein-
ligand complexes (Chang et al., 2013a) and quaternary protein
assemblies (Chang et al., 2013b). To link the structures to the
metabolic model, structural data directly reference the GPRs in
the metabolic reconstruction. For cases of protein-metabolite
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complexes, the metabolites also need to be properly annotated
in the structural data. The structural reconstruction therefore
provides a physical embodiment of the gene-protein-reaction
relationship.
There are a few notable cases demonstrating the unique anal-
ysis possible with the combination of protein structures and
network models. In T. maritima, network context and protein
fold annotations were combined to test alternative models for
pathway evolution (Zhang et al., 2009). The T. maritima GEM-
PRO supported the patchwork model for genesis of new meta-
bolic pathways. In E. coli, the effect of temperature on protein
stability and enzyme activity was simulated at the systems level,
recapitulating the effects of temperature on growth (Chang et al.,
2013a). Also inE. coli, protein-ligand interactionswere combined
with gene essentiality predictions to discover new antibiotic
leads and off-targets (Chang et al., 2013b). These examples
just scratch the surface of analyses made possible with the inte-
gration of network and structural biology.
Modeling Molecular Biology and Metabolism
ME models formalize all of the requirements for biosynthesis
of the functional proteome (Figure 6B). They compute the
proteome composition and its integrated function to produce
phenotypic states and all of the metabolic processes needed
Figure 6. Expansion of Genome-scale
Models to Encompass Molecular Biology
(A) Metabolic models have been expanded to
encompass the processes of proteome synthesis
and localization as well as data on protein struc-
tures. Models including protein synthesis and
localization are referred to as ME models, which
stands formetabolism and gene expression. GEM-
PRO refers to genome-scale models integrated
with protein structures. For GEM-PRO, a combi-
nation of structural data directly references the
GPRs in the metabolic reconstruction; structures
can be obtained from experimental databases or
homology modeling. The E. coli ME model mech-
anistically accounts for 80% of the proteome
mass in conditions of exponential growth and
100% of other major cell constituents (DNA, RNA,
cell wall, lipids, etc.).
(B) Addition of cellular processes vastly increases
the predictive scope of models. ME models
can predict biomass composition, abundances
of protein across subsystems, and differential
gene expression in certain environmental shifts
(in addition to the predictions possible with M
models); like FBA, these were predicted by
assuming growth maximization as an evolutionary
objective, though the specific optimization algo-
rithm differs due to the addition of coupling con-
straints. GEM-PRO has been used to predict
the metabolic bottlenecks and growth defects of
changes in temperature on protein stability and
catalysis; protein stability is predicted with struc-
tural bioinformatics methods and is then used
to limit the catalyzed metabolic flux. The uses of
these integrated models are just beginning to be
explored.
for its synthesis. This represents an inte-
grated view of metabolic biochemistry
and the core processes of molecular
biology. As with GEM-PRO, the first ME
models were formulated for T. maritima (Lerman et al., 2012)
and E. coli (O’Brien et al., 2013; Thiele et al., 2012).
The reconstruction of a ME model starts with the formation of
reactions for gene expression and enzyme synthesis (Thiele
et al., 2009). The processes explicitly accounted for in ME
models are very detailed, including transcription units and
initiation and termination factors for transcription, tRNAs and
chaperones needed for translation and protein folding, andmetal
ion and prosthetic group requirements for catalysis. In other
words, the reconstructions strive to match as closely as possible
all of the biochemical processes required to synthesize fully
functional enzymes. To create a ME model, the reactions for
enzyme synthesis are coupled to the totality of metabolic
reactions with pseudo-kinetic constraints, termed ‘‘coupling
constraints’’ (Lerman et al., 2012; Thiele et al., 2010). These con-
straints relate the abundance of an enzyme (or any ‘‘recyclable’’
chemical species, e.g., mRNA, tRNA) to its degradation rate and
catalytic capacity.
ME models thus significantly expand the scope of possible
phenotype predictions to include aspects of transcription and
translation. RNA and protein biomass composition are variables
in ME models and are no longer set a priori (as in the biomass
objective function of M models). ME models predict the
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experimentally observed linear changes in the ratio of RNA-to-
protein mass fractions as a consequence of changes in protein
synthesis demands (O’Brien et al., 2013). Furthermore, the
mass fractions of protein subsystems agree well with those
predicted by the ME model. This shows that the broad distri-
bution of protein subsystem abundance is predictable using
optimality principles, and the comparison reveals that some
subsystems were under-predicted, thus identifying them as
gaps in knowledge and targets for further reconstruction and
model refinement (Liu et al., 2014). While the quantitative predic-
tion of individual protein abundances is currently beyond the
scope of the ME model (as these demands depend on
enzyme-specific kinetics), the ME model has been shown to
accurately predict differential expression across certain environ-
mental shifts due to the differential requirements of proteins
across conditions (a more qualitative than quantitative predic-
tion) (Lerman et al., 2012).
A recent expansion to the ME model includes the addition of
protein translocation, allowing for the localization of protein to
be computed (Liu et al., 2014) (i.e., into cytoplasm, periplasm,
and inner and outer membrane). Translocase abundances and
compartmentalized proteome mass were accurately predicted
from the bottom up based on optimality principles. Addition of
compartmentalization also allows for membrane area and cyto-
plasmic volume constraints to be formalized, which, if combined
with GEM-PRO, approaches a digital embodiment of a three-
dimensional cell.
Recapitulation
The predictive ability of metabolic models are dictated by the
scope of the reconstruction. Nearly all of the predictions ofmeta-
bolic models outlined in the previous sections can be refined and
expanded with GEM-PRO or ME models. Advances to include
protein structures and protein synthesis open new vistas for
constraint-based modeling.
The scope of genetic perturbations (section 2) that can be
simulated is significantly larger due to the inclusion of genes
for gene expression (and accounting for protein cost) and the
effects of coding mutations on protein structures; GEM-PRO
also expands the scope of environmental perturbation to enable
simulation of changes in temperature. GEM-PRO allows for
new gap-filling approaches (section 3) based on structural bioin-
formaticsmethods. MEmodels expand the scope of quantitative
molecular phenotypes to include transcript and protein levels
(section 4), and transcriptomics and proteomics can be analyzed
in mechanistic detail (section 5).
With the added capabilities of GEM-PRO and MEmodels also
comes additional computational challenges. While single-opti-
mization calculations with M models take less than a second
on a modest laptop computer, growth maximization with a ME
model can take more than an hour. The ME model also requires
specialized high-precision solvers. Many promising applications
of GEM-PRO will require simulation of protein dynamics with
molecular dynamics (MD) and hybrid quantum mechanics/
molecular mechanics (QM/MM) simulations on protein struc-
tures. High-performance computing environments are required
for such simulations, and there is a pervasive trade-off between
the precision of simulations and the scope of structural
coverage. However, advances in high-precision solvers for
ME models (Sun et al., 2013) and structural simulations for
GEM-PRO have been rapid and are likely to ameliorate these
challenges.
Like discoveries enabled by comparing M model predictions
to experimental data, we anticipate that much biology can be
learned from comparing in silico and in vivo proteome allocation
(O’Brien and Palsson, 2015), leading to increasingly predictive
models. The E. coli ME model currently encompasses many
key cellular functions, covering 80% of the proteome by
mass in conditions of exponential growth; the remaining prote-
ome mass outside of the scope of the model can guide model
expansion. In addition to DNA replication and cell division (Karr
et al., 2012), much of the remaining proteome mass involves
cellular stress responses (e.g., pH, osmolarity, osmotic); like
with temperature, GEM-PRO will aid in modeling these cellular
stresses.
Perspective
Genome-scale models have been under development since
the first annotated genome sequences appeared in the late
1990s. For most of this history, the focus of GEMs has been
on metabolism. After initial successes with metabolic GEMs,
it became clear that the same approach could be applied to
other cellular process that could be reconstructed in biochem-
ically accurate detail. Thus, a vision was laid out in 2003
that the path to whole-cell models was conceptually possible
and that such models could be used as a context for mecha-
nistically integrating disparate omic data types (Reed and
Palsson, 2003). This vision is now being realized. This Primer
shows how six grand challenges in cell, molecular, and
systems biology can be addressed using GEMs. A surprising
range of cellular functions and phenotypic states can now be
dealt with.
We now have the tools at hand to develop quantitative geno-
type-phenotype relationships from first principles and at the
genome scale. Current models of prokaryotes account for meta-
bolism, transcription, translation, protein localization, and pro-
tein structure. Processes not described in the currentMEmodels
will be systematically reconstructed over the coming years to
gain a more and more comprehensive description of cellular
functions. Biology can thus look forward to the continued
development and use of a mechanistic framework for the study
of biological phenomena just as physics and chemistry have
enjoyed for over a century.
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